Anti-hIFN beta monoclonal antibody | InvivoGen
Frontiers | Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
Human IFN-Beta 1a, mammalian, carrier-free | PBL Assay Science
Human Type I IFN Neutralizing Antibody Mixture | PBL Assay Science
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
Differential roles of interferons in innate responses to mucosal viral infections: Trends in Immunology
IFN-κ suppresses the replication of influenza A viruses through the IFNAR-MAPK-Fos-CHD6 axis | Science Signaling
Frontiers | Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease
Interferons | Bio-Techne
Interferons Research Area: R&D Systems
The Overview of Interferon-CUSABIO
Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
An Atomic Model of the Interferon-β Enhanceosome: Cell
Interferon type I - Wikipedia
GeneCopoeia: IFN alpha signaling pathway
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram
Interferons: role in cancer therapy | Immunotherapy
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
How cancer cells make and respond to interferon-I: Trends in Cancer
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine
How cancer cells make and respond to interferon-I: Trends in Cancer
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
Interferons Research Area: R&D Systems
Type I Interferon Signaling Pathways
